• Contemporary ClinicContemporary Clinic
  • OTC GuideOTC Guide
  • Pharmacy Times
  • PTCEPTCE
  • Pharmacist Moms GroupPharmacist Moms Group
News
All News
FDA Updates
Press Releases
Media
All Videos
Digital Detail
Independent Corner
Insights
Interviews
MEDcast
Medical World News
Microsites
Peer Exchange
Perfect Consult
Podcasts
Practice Pearls
Sponsored Webcast
Student Voices
Webinars/Webcasts
Conferences
Conference Coverage
Conference Listing
Publications
Pharmacy Times
Pharmacy Practice in Focus: Oncology
Pharmacy Practice in Focus: Health Systems
Pharmacy Careers
All Publications
About the Publications
Author Submission
Submit to Pharmacy Practice in Focus: Oncology
Submit to Pharmacy Practice in Focus: Health Systems
Become a Peer Reviewer
Supplements & Featured Publications
Clinical
503B Compounding Pharmacy
ADHD
Allergy
Alzheimer Disease
Anxiety
Asthma
Atopic Dermatitis
Biosimilars
Bipolar Disorder
Brain Health
Breast Cancer
C. Difficile
COPD
Cardiovascular Health
Cervical Cancer
Cholangiocarcinoma
Cholesterol
Chronic Kidney Disease
Chronic Lymphocytic Leukemia
Classical Hematology
Colorectal Cancer
Continuous Glucose Monitoring
Coronavirus
Cough and Cold
Depression
Dermatology
Diabetes
Digestive Health
Dry Eye Disease
Epilepsy
Eye Care
Flu
Future of Pharmacy
Gastrointestinal Cancer
Gastrointestinal Health
Gout
HER2 Breast Cancer
HIV
Heart Failure
Hematology
Hepatitis/MASH
IVIG
Immunization
Immuno-oncology
Infectious Disease
Lung Cancer
Lymphoma
Macular Degeneration
Mental Health
Migraine
Multiple Myeloma
Multiple Sclerosis
Myelofibrosis
Neurology
Neutropenia
Osteoporosis
Ovarian Cancer
Pain Management
Parkinson Disease
Pediatrics
Pharmacy Heroes
Pharmacy Management
Pneumococcal
PrEP
Prostate Cancer
Psoriasis
Psoriatic Arthritis
Psychedelics
Reimbursement
Reproductive Health
Respiratory Syncytial Virus
Rheumatoid Arthritis
Schizophrenia
Shingles
Skin Cancer
Sleep
Travel Vaccines
Veterinary Pharmacy
Vitamins and Supplements
Weight Management
Women's Health
Events
Upcoming Events
Upcoming Webinars
CE
Resources
Clinical Forum
Cou-Co
Educated Patient
Information for the Pharmacist
Interactive Tools
Partners
Sponsored
Whiteboards
Subscribe
logo
Spotlight
Community/RetailHospitalOncologyPharmacy TechnicianStudent
Clinical Role
Community/RetailHospitalOncologyPharmacy TechnicianSpecialty PharmacyStudent
Clinical
CoronavirusBrain HealthCardiovascular HealthDermatologyDiabetesFluHeart FailureHepatitis/MASHImmunizationMigrainePneumococcalVitamins and Supplements
Supplement Spotlight
October 2023 Pharmacy Technician Edition
All News
FDA Updates
Press Releases
All Videos
Digital Detail
Independent Corner
Insights
Interviews
MEDcast
Medical World News
Microsites
Peer Exchange
Perfect Consult
Podcasts
Practice Pearls
Sponsored Webcast
Student Voices
Webinars/Webcasts
Conference Coverage
Conference Listing
Pharmacy Times
Pharmacy Practice in Focus: Oncology
Pharmacy Practice in Focus: Health Systems
Pharmacy Careers
All Publications
About the Publications
Author Submission
Submit to Pharmacy Practice in Focus: Oncology
Submit to Pharmacy Practice in Focus: Health Systems
Become a Peer Reviewer
Supplements & Featured Publications
503B Compounding Pharmacy
ADHD
Allergy
Alzheimer Disease
Anxiety
Asthma
Atopic Dermatitis
Biosimilars
Bipolar Disorder
Brain Health
Breast Cancer
C. Difficile
COPD
Cardiovascular Health
Cervical Cancer
Cholangiocarcinoma
Cholesterol
Chronic Kidney Disease
Chronic Lymphocytic Leukemia
Classical Hematology
Colorectal Cancer
Continuous Glucose Monitoring
Coronavirus
Cough and Cold
Depression
Dermatology
Diabetes
Digestive Health
Dry Eye Disease
Epilepsy
Eye Care
Flu
Future of Pharmacy
Gastrointestinal Cancer
Gastrointestinal Health
Gout
HER2 Breast Cancer
HIV
Heart Failure
Hematology
Hepatitis/MASH
IVIG
Immunization
Immuno-oncology
Infectious Disease
Lung Cancer
Lymphoma
Macular Degeneration
Mental Health
Migraine
Multiple Myeloma
Multiple Sclerosis
Myelofibrosis
Neurology
Neutropenia
Osteoporosis
Ovarian Cancer
Pain Management
Parkinson Disease
Pediatrics
Pharmacy Heroes
Pharmacy Management
Pneumococcal
PrEP
Prostate Cancer
Psoriasis
Psoriatic Arthritis
Psychedelics
Reimbursement
Reproductive Health
Respiratory Syncytial Virus
Rheumatoid Arthritis
Schizophrenia
Shingles
Skin Cancer
Sleep
Travel Vaccines
Veterinary Pharmacy
Vitamins and Supplements
Weight Management
Women's Health
Upcoming Events
Upcoming Webinars
CE
Clinical Forum
Cou-Co
Educated Patient
Information for the Pharmacist
Interactive Tools
Partners
Sponsored
Whiteboards
Subscribe
Advertisement

CLINICAL ROLE -

Community/Retail
| Hospital
| Oncology
| Pharmacy Technician
| Student

Article

June 27, 2017

Trending News Today: Monsanto's Weed Killer Added to List of Cancer-Causing Chemicals

Author(s):

Lauren Santye, Assistant Editor

Top news of the day from across the health care landscape.

California will add the main active ingredient in Monsanto Co’s Roundup weed killer to its list of chemicals known to cause cancer starting July 7, 2017, according to Reuters. Glyphosate was first approved for use in the United States in 1974, and is a one of the most widely used herbicides in the United States. California’s Office of Environmental Health Hazard Assessment said that the designation of glyphosate under Proposition 65 would require companies selling products that contain the chemical to add warning labels to packaging. Furthermore, warnings would also be required if glyphosate is sprayed at levels deemed unsafe by regulators, Reuters reported. Monsanto and other companies producing glyphosate will have approximately 1 year from the listing date to relabel products or remove them from the store shelves. Monsanto said in a statement that the decision is “unwarranted on the basis of science and the law,” and vows to continue fighting the legal battle against the designation, according to the report.

A former compounding pharmacist was convicted for his involvement in the deadly 2012 outbreak of fungal meningitis in the United States, reported The New York Times. Barry J. Cadden, former co-owner and head pharmacist of the New England Compound Center, was sentenced to 9 years in prison. According to the CDC, the Massachusetts-based pharmacy made injected steroid pain medication that caused more than 750 cases of fungal meningitis in 20 states, including at least 64 deaths. Cadden was charged under the Racketeer Influenced and Corrupt Organizations Act, and was convicted this year of more than 50 counts of mail fraud and racketeering, but was acquitted of 25 counts of second-degree murder and other charges.

Findings from a new study reveal that physical activity levels among adolescents are similar to that of 60-year-olds, according to The Washington Post. For the study, investigators used data from the National Health and Nutrition Examination Survey to analyze 12,529 participants who wore tracking devices for 1 week straight, only being removed at bedtime or when taking a bath. The devices were used to measure length of sedentary behavior or engagement in light or moderate-to-vigorous physical activity. The results of the study showed that more than 25% of boys and 50% of girls aged 6 to 11 years and more than 50% of males and 75% of female adolescents aged 12 to 19 years did not meet the World Health Organization’s (WHO) recommendations. According to the Post, the WHO recommends at least 60 minutes of moderate-to-vigorous physical activity per day for children ages 5 to 17 years. “Activity levels at the end of adolescence was alarmingly low, and by age 19 [years], they were comparable to 60-year-olds,” senior author Vadim Zipunnikov told the Post. “… The goal of campaigns aimed at increasing physical activity has focused on increasing higher-intensity exercise. Our study suggests that these efforts should consider the time of day and also focus on increasing lower-intensity physical activity and reducing inactivity.”

Related Videos
Pharmacist and patient in a retail/community pharmacy setting -- Image credit: Zamrznuti tonovi | stock.adobe.com
Menoapuse spelled with wooden blocks -- Image credit: loran4a | stock.adobe.com
Related Content
Advertisement
Teal ribbon for ovarian cancer awareness -- Image credit: Queenmoonlite Studio | stock.adobe.com
May 8th 2025

FDA Approves Avutometinib/Defactinib for Adults With KRAS-Mutated Recurrent LGSOC

Gillian McGovern, Associate Editor
Pharmacy Times pharmacy focus oncology edition
May 5th 2025

Novel HER2-low Therapies and Pharmacist-Led ADC Sequencing

Alexandra Gerlach, Associate Editor
Microscopic view of abnormal plasma cell growth in bone marrow | Image Credit: © Diane - stock.adobe.com
May 8th 2025

FDA Grants Fast Track Designation to IBS 2001, An Investigational Trispecific Antibody for Multiple Myeloma

Alexandra Gerlach, Associate Editor
Insights from a Pharmacy Times Peer Exchange: ADC Drug Design and HER2 Ultra-Low Breast Cancer Indiciations
April 29th 2025

Insights from a Pharmacy Times Peer Exchange: ADC Drug Design and HER2 Ultra-Low Breast Cancer Indiciations

Alexandra Gerlach, Associate Editor
Newborn baby -- Image credit: kieferpix | stock.adobe.com
May 8th 2025

INF108 Granted Orphan Drug Designation, Rare Pediatric Drug Designation for Preterm Infants With NEC

Gillian McGovern, Associate Editor
GLP-1 and Side Effects newspaper headlines with magnifying glass
May 8th 2025

Asembia AXS25: Navigating the Transformative Landscape of GLP-1 Medications

Luke Halpern, Assistant Editor
Related Content
Advertisement
Teal ribbon for ovarian cancer awareness -- Image credit: Queenmoonlite Studio | stock.adobe.com
May 8th 2025

FDA Approves Avutometinib/Defactinib for Adults With KRAS-Mutated Recurrent LGSOC

Gillian McGovern, Associate Editor
Pharmacy Times pharmacy focus oncology edition
May 5th 2025

Novel HER2-low Therapies and Pharmacist-Led ADC Sequencing

Alexandra Gerlach, Associate Editor
Microscopic view of abnormal plasma cell growth in bone marrow | Image Credit: © Diane - stock.adobe.com
May 8th 2025

FDA Grants Fast Track Designation to IBS 2001, An Investigational Trispecific Antibody for Multiple Myeloma

Alexandra Gerlach, Associate Editor
Insights from a Pharmacy Times Peer Exchange: ADC Drug Design and HER2 Ultra-Low Breast Cancer Indiciations
April 29th 2025

Insights from a Pharmacy Times Peer Exchange: ADC Drug Design and HER2 Ultra-Low Breast Cancer Indiciations

Alexandra Gerlach, Associate Editor
Newborn baby -- Image credit: kieferpix | stock.adobe.com
May 8th 2025

INF108 Granted Orphan Drug Designation, Rare Pediatric Drug Designation for Preterm Infants With NEC

Gillian McGovern, Associate Editor
GLP-1 and Side Effects newspaper headlines with magnifying glass
May 8th 2025

Asembia AXS25: Navigating the Transformative Landscape of GLP-1 Medications

Luke Halpern, Assistant Editor
Consent Preferences
About Us
Clinical Forums
Advertise
Contact Us
Editorial Staff
Privacy Policy
Terms & Conditions
Do Not Sell My Information
Contact Info

2 Commerce Drive
Cranbury, NJ 08512

609-716-7777

© 2025 MJH Life Sciences

All rights reserved.